PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.16%
Negative revenue growth while QCOM stands at 23.55%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.91%
Negative gross profit growth while QCOM is at 24.79%. Joel Greenblatt would examine cost competitiveness or demand decline.
133.15%
EBIT growth above 1.5x QCOM's 69.07%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
184.17%
Operating income growth above 1.5x QCOM's 69.07%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
37.12%
Net income growth at 50-75% of QCOM's 49.96%. Martin Whitman would question fundamental disadvantages in expenses or demand.
39.13%
EPS growth at 75-90% of QCOM's 49.33%. Bill Ackman would push for improved profitability or share repurchases to catch up.
39.13%
Diluted EPS growth at 75-90% of QCOM's 49.32%. Bill Ackman would expect further improvements in net income or share count reduction.
-0.54%
Share reduction while QCOM is at 0.29%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.09%
Reduced diluted shares while QCOM is at 0.34%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.74%
Dividend reduction while QCOM stands at 0.18%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-66.82%
Negative OCF growth while QCOM is at 40.17%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-72.09%
Negative FCF growth while QCOM is at 52.72%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
98.72%
10Y revenue/share CAGR under 50% of QCOM's 402.79%. Michael Burry would suspect a lasting competitive disadvantage.
5.70%
5Y revenue/share CAGR under 50% of QCOM's 135.96%. Michael Burry would suspect a significant competitive gap or product weakness.
0.26%
3Y revenue/share CAGR under 50% of QCOM's 120.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
177.32%
10Y OCF/share CAGR under 50% of QCOM's 447.80%. Michael Burry would worry about a persistent underperformance in cash creation.
-32.68%
Negative 5Y OCF/share CAGR while QCOM is at 114.71%. Joel Greenblatt would question the firm’s operational model or cost structure.
-43.52%
Negative 3Y OCF/share CAGR while QCOM stands at 55.95%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
367.16%
Net income/share CAGR at 50-75% of QCOM's 623.95%. Martin Whitman might question if the firm’s product or cost base lags behind.
-34.45%
Negative 5Y net income/share CAGR while QCOM is 137.74%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-38.72%
Negative 3Y CAGR while QCOM is 121.73%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
54.13%
Below 50% of QCOM's 448.87%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
33.19%
Below 50% of QCOM's 116.55%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
24.41%
Below 50% of QCOM's 61.89%. Michael Burry suspects a serious short-term disadvantage in building book value.
846.73%
Dividend/share CAGR of 846.73% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
109.10%
Dividend/share CAGR of 109.10% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
73.43%
3Y dividend/share CAGR above 1.5x QCOM's 47.44%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.37%
AR growth well above QCOM's 12.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.24%
Inventory is declining while QCOM stands at 23.98%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.81%
Negative asset growth while QCOM invests at 4.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.46%
Under 50% of QCOM's 5.08%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.05%
We’re deleveraging while QCOM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-1.41%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
6.74%
We expand SG&A while QCOM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.